NEJM (@nejm) 's Twitter Profile
NEJM

@nejm

The New England Journal of Medicine is the world’s leading medical journal and website.

ID: 25950355

linkhttp://NEJM.org calendar_today23-03-2009 04:10:07

34,34K Tweet

934,934K Takipçi

430 Takip Edilen

NEJM (@nejm) 's Twitter Profile Photo
NEJM
@nejm

2 years ago

In this trial involving 387 patients with Staphylococcus aureus bacteremia, ceftobiprole, a cephalosporin active against methicillin-sensitive and -resistant S. aureus, was noninferior to daptomycin. Read the full results of the ERADICATE trial: nej.md/3ESlZmk